Clinical Trial Alert

Nephrology Times:
doi: 10.1097/01.NEP.0000426015.46579.98
Clinical Trial Alert

    The following is a partial list of new clinical trials recently added to the National Institutes of Health's ClinicalTrials.gov online registry. More information on these trials is available at www.clinicaltrials.gov.

    Back to Top | Article Outline

    • Acute Kidney Injury •

    NCT01735162

    Study of the Prediction of Acute Kidney Injury in Children Using Risk Stratification and Biomarkers

    Ages eligible for study: Not listed

    Sponsors and collaborators: Cincinnati Children's Hospital Medical Center

    Contact: Rajit Basu, MD

    Phone: 513-636-4259

    E-mail: rajit.basu@cchmc.org

    Contact: Stuart Goldstein, MD

    Phone: 513-636-2209

    E-mail: stuart.goldstein@cchmc.org

    Back to Top | Article Outline
    NCT01721928

    Norwegian Intensive Care Unit Dalteparin Effect Study

    Ages eligible for study: 18 years and older

    Sponsors and collaborators: Oslo University Hospital, University of Oslo

    Contact: Sigrid Beitland, MD

    Phone: +4722117387

    E-mail: sigrid.beitland@medisin.uio.no

    Contact: Kjetil Sunde

    Phone: +4722119585

    E-mail: kjetil.sunde@medisin.uio.no

    Back to Top | Article Outline

    • Cardiovascular Disease •

    NCT01709994

    Primary Cardiovascular Risk Prevention with Aspirin in Chronic Kidney Disease Patients

    Ages eligible for study: 45 years to 79 years

    Sponsors and collaborators: Fundación de Ayuda a la Investigación sobre la Hipertensión, Riesgo Cardiovascular y Enfermedades Renales

    Contact: Jose Luño, MD, PhD

    Phone: 0034915868319

    E-mail: jluno.hgugm@salud.madrid.org

    Back to Top | Article Outline
    NCT01711723

    A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Repeat Oral Doses of Darapladib (SB-480848) in Subjects with Severe Renal Impairment

    Ages eligible for study: 18 years to 75 years

    Sponsors and collaborators: GlaxoSmithKline

    Contact: US GSK Clinical Trials Call Center

    Phone: 877-379-3718

    E-mail: gskclinicalsupporthd@gsk.com

    Back to Top | Article Outline

    • Chronic Kidney Disease •

    NCT01701830

    Serum Omentin-1 and Carotid Atherosclerosis in Nondiabetic Chronic Kidney Disease

    Ages eligible for study: 18 years to 75 years

    Sponsors and collaborators: Kocaeli Derince Education and Research Hospital

    Contact: Rabia Terzi, MD

    Phone: 90262 317 80 00, ext. 8110

    E-mail: drrabia1@yahoo.com

    Back to Top | Article Outline
    NCT01717248

    Safety Study of GCS-100 to Treat Chronic Kidney Disease

    Ages eligible for study: 18 years to 75 years

    Sponsors and collaborators: La Jolla Pharmaceutical Company

    Contact: George Tidmarsh, MD, PhD

    Phone: 650-208-3191

    E-mail: gtidmarsh@ljpc.com

    Back to Top | Article Outline

    • Chronic Kidney Disease–Mineral and Bone Disorder •

    NCT01704079

    Safety and Efficacy of CTAP101 Capsules for Treatment of SHPT and Vitamin D Insufficiency

    Ages eligible for study: 18 years to 85 years

    Sponsors and collaborators: Cytochroma

    Contact: Rose Green, RPh

    Phone: 847-236-7707, ext. 204

    E-mail: rose.green@cytochroma.com

    Contact: Joel Melnick, MD

    Phone: 847-236-7707, ext. 243

    E-mail: joel.melnick@cytochroma.com

    Back to Top | Article Outline

    • Diabetes •

    NCT01712061

    A Phase 2 Multicenter Study to Evaluate the Efficacy and Safety of a Chemokine CCR2/5 Receptor Antagonist in Adults with Type 2 Diabetes and Overt Nephropathy

    Ages eligible for study: 18 years and older

    Sponsors and collaborators: Pfizer

    Contact: Pfizer CT.gov Call Center

    Phone: 800-718-1021

    Back to Top | Article Outline

    • End-Stage Renal Disease •

    NCT01704339

    Qutenza for Critical Ischemia in End-Stage Renal Failure

    Ages eligible for study: 18 years and older

    Sponsors and collaborators: Emma Aitken, NHS Greater Glasgow and Clyde

    Contact: Emma L. Aitken, MBChB

    Phone: 01412111750

    E-mail: EmmaAitken@nhs.net

    Contact: David B. Kingsmore, MBChB

    Phone: 01412111750

    E-mail: david.kinsgmore@ggc.scot.nhs.uk

    Back to Top | Article Outline
    NCT01706354

    Local Anesthesia vs Regional Block for Arteriovenous Fistulae

    Ages eligible for study: 18 years and older

    Sponsors and collaborators: Emma Aitken, NHS Greater Glasgow and Clyde

    Contact: Marc Clancy, MBBS, PhD

    Phone: 0141 211 1750

    E-mail: Marc.Clancy@ggc.scot.nhs.uk

    Contact: Emma Aitken, MBChB, MRCS

    Phone: 0141 211 1750

    E-mail: Emma.Aitken@nhs.net

    Back to Top | Article Outline
    NCT01704313

    A Trial of Interrupted vs Continuous Suturing Techniques for Radiocephalic Fistulae

    Ages eligible for study: 18 years and older

    Sponsors and collaborators: Emma Aitken, NHS Greater Glasgow and Clyde

    Contact: Emma L. Aitken, MBChB

    Phone: 01412111750

    E-mail: EmmaAitken@nhs.net

    Contact: David B. Kingsmore, MBChB

    Phone: 01412111750

    E-mail: david.kingsmore@ggc.scot.nhs.uk

    Back to Top | Article Outline

    • Hypertension •

    NCT01737138

    Renal Sympathetic Denervation in Patients with Chronic Kidney Disease and Resistant Hypertension Ages eligible for study: 18 years to 75 years

    Sponsors and collaborators: The First Hospital of Nanjing Medical University

    Contact: Shan Qi Jun

    Phone: 0086 025 68136407

    E-mail: qjshan@njmu.edu.cn

    Back to Top | Article Outline
    NCT01713270

    Renal Sympathetic Denervation in Patients with Hypertension and Symptomatic Atrial Fibrillation

    Ages eligible for study: 18 years to 75 years

    Sponsors and collaborators: The First Hospital of Nanjing Medical University

    Contact: Qijun Shan

    Phone: 0086 025 68136407

    E-mail: qjshan@njmu.edu.cn

    Back to Top | Article Outline
    NCT01703780

    The Diagnosis and Treatment of Resistant Hypertension, the Prevalence and the Prognosis

    Ages eligible for study: 30 years to 75 years

    Sponsors and collaborators: Cardiovascular Institute & Fuwai Hospital, Huazhong University of Science & Technology, Shanghai Jiao Tong University School of Medicine

    Contact: Rutai Hui

    Phone: 86-010-88398154

    E-mail: huirutai@gmail.com

    Back to Top | Article Outline
    NCT01712620

    Spironolactone for Pulmonary Arterial Hypertension

    Ages eligible for study: 18 years and older

    Sponsors and collaborators: National Institutes of Health Clinical Center (CC); National Heart, Lung, and Blood Institute (NHLBI); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University of Pennsylvania; University of Maryland Medical Center; Washington Hospital Center

    Contact: Grace M. Graninger, RN

    Phone: 301-496-9320

    E-mail: ggraninger@cc.nih.gov

    Contact: Michael A. Solomon, MD

    Phone: 301-496-9320

    E-mail: msolomon@cc.nih.gov

    Back to Top | Article Outline
    NCT01702688

    Evaluation of Lysine-Specific Demethylase 1

    Ages eligible for study: 18 years to 65 years

    Sponsors and collaborators: Brigham and Women's Hospital

    Contact: Bindu Chamarthi, MD

    Phone: 617-732-5666

    E-mail: bchamarthi@partners.org

    Back to Top | Article Outline

    • Sepsis •

    NCT01682590

    I.D.E.A.L.-I.C.U. (Initiation of Dialysis EArly Versus Late in Intensive Care Unit)

    Ages eligible for study: 18 years and older

    Sponsors and collaborators: Centre Hospitalier Universitaire Dijon

    Contact: Jean-Pierre Quenot

    Phone: 3 80 29 36 85, ext. 33

    E-mail: jean-pierre.quenot@chu-dijon.fr

    Back to Top | Article Outline

    • Miscellaneous •

    NCT01671228

    Developing and Evaluating the Yorkshire Dialysis Decision Aid

    Ages eligible for study: 18 years and older

    Sponsors and collaborators: University of Leeds, Kidney Research UK, National Health Service, Baxter Healthcare Corporation, Foundation for Informed Medical Decision Making, X-Lab Systems

    Contact: Hilary L. Bekker, PhD

    Phone: 0113-343-2726

    E-mail: h.l.bekker@leeds.ac.uk

    Contact: Martin Wilkie, MD

    Phone: 0114-271-5327

    E-mail: martin.wilkie@sth.nhs.uk

    Back to Top | Article Outline
    NCT01685658

    Intravenous Paracetamol Versus Ketoprofen When Treating Renal Colic in Emergency Situations

    Ages eligible for study: 18 years and older

    Sponsors and collaborators: Centre Hospitalier Universitaire de Nīmes

    Contact: Pierre-Géraud Claret, MD

    Phone: +33 (0) 4 66 68 80 83

    E-mail: pierre.geraud.claret@gmail.com

    Contact: Carey Suehs, PhD

    Phone: +33 (0) 4 66 68 67 88

    E-mail: carey.suehs@chu-nimes.fr

    Back to Top | Article Outline
    NCT01690039

    Influence of Polymorphisms in the ATP6V1 Gene of the V-ATPase on the Development of Incomplete Distal Renal Tubular Acidosis

    Ages eligible for study: 18 years and older

    Sponsors and collaborators: Bern University Hospital

    Contact: Daniel Fuster

    Phone: +41 (0) 31 631 37 49

    E-mail: daniel.fuster@ibmm.unibe.ch

    Contact: Nasser Dhayat

    Phone: +41 (0) 31 632 31 44

    E-mail: nasser.dhayat@insel.ch

    Back to Top | Article Outline
    NCT01711853

    Study in Severe Renal Patients to Investigate Dabigatran Etexilate

    Ages eligible for study: 18 years to 80 years

    Sponsors and collaborators: Boehringer Ingelheim Pharmaceuticals

    Contact: Boehringer Ingelheim Call Center

    Phone: 800-243-0127

    E-mail: clintriage.rdg@boehringer-ingelheim.com

    Back to Top | Article Outline
    NCT01705132

    Urinary Biomarkers of the Progression of Alport Kidney Disease

    Ages eligible for study: 5 years to 65 years

    Sponsors and collaborators: University of Minnesota Clinical and Translational Science Institute, Novartis

    Contact: Theresa Cassidy, MPH, CCRP

    Phone: 612-626-7632

    E-mail: cassi044@umn.edu •

    © 2012 Lippincott Williams & Wilkins, Inc.